Arvind Remedies inks MoU with SRM University for diabetes and heart drugs
These drugs will be launched in the domestic market by 2015
The Chennai-based Arvind Remedies Ltd has signed a Memorandum of Understanding (MoU) with SRM University, Chennai, to transfer the patent right to undertake exclusive manufacturing and marketing of drugs for type II diabetes and coronary heart disease. “These drugs will be manufactured in the form of tablets and will be launched in the domestic market by 2015 followed by the global market. The diabetes drug is from the botanical source to ensure zero side effects on the health of patients,” said Arvind Remedies in a BSE filing.
In October last year, Arvind Remedies had signed an MoU with four institutions namely Banaras Hindu University, Adesh University, SRM University and Genome Foundation to the manufacture and market medicines from botanical source. Under the agreement, Arvind Remedies and the institutions together have developed and patented medicines which are useful for the treatment and management of neurodegeneration disorder (like Alzheimer’s, Parkinson’s) and neuropsychiatric disorders (like depression). The said medicines have been patented in India, USA and Europe.
In October last year, Arvind Remedies had signed an MoU with four institutions namely Banaras Hindu University, Adesh University, SRM University and Genome Foundation to the manufacture and market medicines from botanical source. Under the agreement, Arvind Remedies and the institutions together have developed and patented medicines which are useful for the treatment and management of neurodegeneration disorder (like Alzheimer’s, Parkinson’s) and neuropsychiatric disorders (like depression). The said medicines have been patented in India, USA and Europe.